IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FOA, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.273
AS - Asia 4.150
NA - Nord America 3.928
SA - Sud America 440
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 17
Totale 14.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.788
GB - Regno Unito 1.932
DE - Germania 1.498
SG - Singapore 1.249
CN - Cina 1.217
SE - Svezia 788
IT - Italia 523
RU - Federazione Russa 488
VN - Vietnam 364
BR - Brasile 342
HK - Hong Kong 318
TR - Turchia 304
FR - Francia 257
KR - Corea 207
IE - Irlanda 178
NL - Olanda 152
FI - Finlandia 147
UA - Ucraina 141
EU - Europa 135
IN - India 128
BD - Bangladesh 107
CA - Canada 101
JP - Giappone 65
ID - Indonesia 39
PL - Polonia 31
ZA - Sudafrica 30
AR - Argentina 29
CO - Colombia 27
BE - Belgio 25
MX - Messico 24
PK - Pakistan 23
ES - Italia 22
IQ - Iraq 22
AT - Austria 17
MY - Malesia 14
UZ - Uzbekistan 14
CI - Costa d'Avorio 13
CL - Cile 13
GR - Grecia 13
AU - Australia 12
EC - Ecuador 11
DK - Danimarca 10
MA - Marocco 10
PH - Filippine 10
RO - Romania 10
VE - Venezuela 10
CZ - Repubblica Ceca 9
JO - Giordania 9
CH - Svizzera 8
SA - Arabia Saudita 8
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
NP - Nepal 6
TN - Tunisia 6
TW - Taiwan 6
BG - Bulgaria 4
IL - Israele 4
IR - Iran 4
KZ - Kazakistan 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
DZ - Algeria 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
NI - Nicaragua 3
PA - Panama 3
GE - Georgia 2
KG - Kirghizistan 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
PY - Paraguay 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MU - Mauritius 1
PE - Perù 1
RS - Serbia 1
Totale 15.017
Salva come PNG Salva come JPEG
Città #
Southend 1.791
Frankfurt am Main 915
Singapore 719
Chandler 359
Hong Kong 302
Seattle 288
Ashburn 273
San Jose 248
Munich 212
Beijing 209
Princeton 207
Wilmington 182
Dublin 175
Milan 151
Dallas 138
Council Bluffs 129
Redmond 123
Ann Arbor 104
Nanjing 104
Hanoi 89
Sakarya 85
Mountain View 83
Lauterbourg 82
Los Angeles 82
Des Moines 81
Ho Chi Minh City 81
Moscow 74
Dearborn 72
Guangzhou 70
Jacksonville 70
Bengaluru 67
Santa Clara 66
Buffalo 65
Toronto 65
Fairfield 61
Boardman 57
New York 53
Woodbridge 53
Shanghai 52
Eitensheim 51
Dong Ket 44
The Dalles 44
Helsinki 43
Andover 41
Columbus 41
Nanchang 41
Serra 37
Jinan 36
Tianjin 34
Shenyang 33
São Paulo 33
Cambridge 31
Grafing 30
Redwood City 30
Houston 29
Seoul 29
Tokyo 29
Hefei 26
Warsaw 25
Changsha 24
Hebei 24
Johannesburg 24
Bogotá 22
Saint Petersburg 22
Berlin 20
Brussels 20
Kunming 19
Somerville 19
Haiphong 18
Phoenix 17
Jakarta 16
Shenzhen 16
San Diego 15
Taizhou 14
Abidjan 13
Hangzhou 13
Jiaxing 13
Rio de Janeiro 13
Rome 13
Cangzhou 12
Da Nang 12
Mumbai 12
Scranton 12
Vienna 12
Athens 11
Fuzhou 11
Tappahannock 11
Tashkent 11
Turku 11
Chicago 10
Lanzhou 10
Ningbo 10
Nuremberg 10
Zhengzhou 10
Amman 8
Brasília 8
Dhaka 8
Falls Church 8
Florence 8
London 8
Totale 9.312
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 570
Rhodococcus equi infection in a patient with spinocellular carcinoma of unknown origin 377
Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population 364
1,25-DIHYDROXYVITAMIN-D3 AND MYELOPROLIFERATIVE SYNDROMES 343
1,25-DIHYDROXYVITAMIN-D3 IN THE TREATMENT OF IDIOPATHIC THROMBOCYTHEMIA AND MYELOFIBROSIS 313
An unusual case of tracheo-pleural fistula and cardiac metastases in oropharyngeal carcinoma: a case report and review of the literature 293
miR-296/scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo 292
Detecting disabilities in older patients with cancer : comparison between comprehensive geriatric assessment and vulnerable elders survey-13 278
Clinical analysis of multiple primary malignancies in the elderly 259
Multimodality treatment of osteosarcoma of the jaw : a single institution experience 256
Anti-epidermal growth factor receptor skin toxicity : a matter of topical hydration 241
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial 240
Fatigue and functional dependence in older cancer patients 234
A review on the treatment of relapsed/metastatic head and neck cancer 232
Interventi di supporto per pazienti oncologici : un'esperienza di psicodramma classico 228
A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer 226
Reply to M.J. Molina-Garrido et al 226
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer : the VanGogh study 224
COMBINED SURGERY AND POST-OPERATIVE RADIOTHERAPY OR CHEMORADIOTHERAPY FOR LOCALLY ADVANCED TONGUE CANCER 222
BIOMOLECULAR MARKERS IN TONGUE CANCER 217
Estimating the risk of chemotherapy toxicity in older patients with cancer : the role of the Vulnerable Elders Survey-13 (VES-13) 217
Reply to C. Falci et al 213
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma 211
ANTIBIOTICS FOR DERMATITIS INDUCED BY CETUXIMAB AND CONCOMITANT RADIOTHERAPY 209
Do elderly cancer patients achieve an adequate dose intensity in common clinical practice? 204
Adjuvant chemotherapy in completely resected gastric cancer : a randomized phase III trial conducted by GOIRC 203
The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients 194
Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA) 190
Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels as prognostic indicators in resected non-small cell lung cancer 187
BIOLOGICAL CHARACTERIZATION OF REFRACTORY-ANEMIA WITH EXCESS OF BLASTS 170
Multimarker phenotypic characterization of adult and childhood acute lymphoblastic leukaemia: an Italian multicentre study 163
Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicity 160
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer 158
Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer 157
Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer 155
A protocol of intervention for the psychological consultation in an oncological ward : a theoretical proposal 153
Evaluation of the soluble fragments of cytokeratin 19 (CK19) in non-small cell lung cancer (NSCLC): Comparison with TPA, CEA, SCC and NSE 148
Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer. 147
INHIBITORY ACTIVITY OF A SYNTHETIC PENTAPEPTIDE ON LEUKEMIC MYELOPOIESIS BOTH INVITRO AND INVIVO IN RATS 147
Chronic neutrophilc leukaemia associated with polycythemia vera: pathogenetic implications and therapeutic approach 146
Non interference by heparin with the cytostatic effect of adriamycin: an in vitro study on a human promyelocytic leukaemia cell line 144
Locoregionally advanced nasopharyngeal carcinoma : induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin : a phase II study 142
CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING RADIATION-THERAPY FOR TESTICULAR SEMINOMA 142
Growth pattern of a transplantable acute myeloid leukemia in the rat 140
AUTOIMMUNE HEMOLYTIC-ANEMIA IN A PATIENT WITH IDIOPATHIC HYPEREOSINOPHILIA 139
Efficacy and safety of low-dose aspirin in polycythemia vera 137
Flow cytometric analysis of cellular DNA in human acute nonlymphatic leukemias and dysmyelopoietic syndromes 133
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia 130
LOW-DOSE CYTOSINE-ARABINOSIDE (ARA-C) THERAPY IN THE MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOGENOUS LEUKEMIA 130
Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial 129
Chronic myeloid leukemia treated with busulfan: Relationship between total amount of drug required during the first year of treatment and duration of chronic phase 129
Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial 128
BONE-MARROW BIOPSY IN CHRONIC MYELOID-LEUKEMIA - SIGNIFICANCE OF SOME HISTOLOGICAL PARAMETERS 127
Antiproliferative activity of cyclosporin A on human T-lymphoblastic leukaemia cell line 127
INVITRO BIOLOGICAL-ACTIVITY OF A SYNTHETIC PENTAPEPTIDE OF MYELOID CELLS 126
INHIBITION OF PROLIFERATION OF HUMAN-LEUKEMIC CELL-POPULATIONS BY DEFEROXAMINE 124
Adjuvant chemotherapy in complete resected gastric cancer: evaluation in double left arrow 60 vs > 60 years pts 124
Clinical relevance of immunoreactive-calcitonin plasma levels in human myeloid leukemias 124
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients 123
REFRACTORY-ANEMIA WITH EXCESS OF BLASTS - A FLOW-CYTOMETRY STUDY OF INTRACELLULAR DNA 123
EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN 1984 AND 1986 123
Targeted therapies : cui prodest? 121
IMMUNOHISTOCHEMICAL EVALUATION OF BONE-MARROW BIOPSIES IN MYELODYSPLASTIC SYNDROMES 121
Growth pattern of the human promyelocytic leukaemia cell line HL60 121
SUPPRESSIVE BIOLOGICAL-ACTIVITY OF A SYNTHETIC PENTAPEPTIDE ON HIGHLY ENRICHED HUMAN AND MURINE MARROW HEMATOPOIETIC PROGENITORS - SYNERGISM WITH RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON-GAMMA 120
Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera 119
CYCLOSPORINE-A IN THE TREATMENT OF SEVERE APLASTIC-ANEMIA - DESCRIPTION OF A CASE COMPLICATED BY THE DEVELOPMENT OF TUBERCULAR PERICARDITIS DURING TREATMENT 119
THE ROLE OF 99mTc-TETROFOSMIN SCINTIGRAPHY IN STAGING AND MONITORING THE RESPONSE TO THERAPY IN HODGKIN'S AND NON HODGKIN'S LYMPHOMAS: CORRELATION WITH CT SCAN, GALLIUM-67 CITRATE AND P-GLYCOPROTEIN EXPRESSION 119
Risk factors for elastic transformation in myelofibrosis with myeloid metaplasia (MMM) 118
IN-VITRO SENSITIVITY OF HUMAN ERYTHROID PROGENITORS TO HEMATOPOIETIC GROWTH-FACTORS - STUDIES ON PRIMARY AND SECONDARY POLYCYTHEMIA 118
In vitro production of lymphocyte and granulocyte proliferation inhibitors (chalones?) from living cells 118
Polycythemia vera treated with recombinant interferon-alpha 2a: Evidence of a selective effect on the malignant clone 117
Detailed kinetic analysis of Shay chloroleukaemia cell population propagated in permanent suspension culture in vitro 117
Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy 116
Effect of granulocytic chalone on the growth rate of continuous cell lines propagated in vitro : a new assay system 116
Immunoreactive calcitonin in myeloid leukemias 116
Fluorescence in situ hybridization (FISH) for evaluating residual disease in Philadelphia chromosome-positive chronic myeloid leukemia during interferon alpha therapy 114
ROLE OF INTERFERON ALPHA-2A IN THE TREATMENT OF POLYCYTHEMIA-VERA 114
INVITRO AND INVIVO INHIBITION IN THE ANIMAL OF LEUKEMIC MYELOPOIESIS BY A SYNTHETIC PENTAPEPTIDE 113
RENAL-CANCER AFTER BUSULFAN TREATMENT FOR CHRONIC MYELOID-LEUKEMIA - A CASE-REPORT 111
Biological determinants of long-term survival in chronic myelogenous leukemia patients treated with conventional chemotherapy 110
DOUBLE-STRANDED-RNA EXCESS IN HUMAN HEMATOLOGICAL MALIGNANCIES 109
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study 109
Gemoxi a gentle treatment in patients with advanced pancreatic cancer 108
Immunoreactive calcitonin : a new tumor marker of myelogenous leukemias? 108
Immunoreactive calcitonin in myeloid leukemias 106
Granulocytic chalone is not a polyamine complex 104
Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony-stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy (vol 107, pg 330, 1999) 103
ERYTHROPOIETIN - CLINICAL-APPLICATIONS 98
RENAL-CANCER AFTER BUSULFAN TREATMENT FOR CHRONIC MYELOID-LEUKEMIA - THERAPEUTIC IMPLICATIONS 97
Polycythemia vera terminating in chronic neutrophilic leukemia: report of a case 96
Palmar-plantar erythrodysaesthesia syndrome due to 5-fluorouracil therapy - An underestimated toxic event? 95
DEFEROXAMINE INHIBITS INVITRO PROLIFERATION OF HUMAN-LEUKEMIC CELLS 94
CONFIRMATION AND IMPROVEMENT OF SOKAL PROGNOSTIC CLASSIFICATION OF PH+ CHRONIC MYELOID-LEUKEMIA - THE VALUE OF EARLY EVALUATION OF THE COURSE OF THE DISEASE 93
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) 88
Totale 15.657
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.677
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021482 0 0 0 0 0 0 0 0 0 0 360 122
2021/2022928 104 53 23 68 44 60 86 31 86 84 131 158
2022/20231.334 186 117 120 149 149 300 30 90 118 9 54 12
2023/20241.297 30 76 60 52 160 40 131 126 61 172 189 200
2024/20252.132 197 240 137 286 149 96 89 220 120 139 144 315
2025/20263.375 329 207 336 263 355 290 511 199 442 210 233 0
Totale 15.657